48岁的王女士确诊晚期肺腺癌，EGFR 19外显子缺失突变，奥西替尼一线治疗让肿瘤缩小了70%。但18个月后，CT显示肺部新发结节——奥西替尼耐药来了。她的故事不是个例： ...

Amivantamab has been approved for the treatment of patients with advanced non–small-cell lung cancer (NSCLC) with epidermal ...